-
AI pharmaceutical research and development is hot, and transaction cooperation has gradually become an industry trend
Time of Update: 2023-01-06
On October 11, Illumina announced a strategic research collaboration with AstraZeneca to accelerate drug target discovery by combining the strengths of both companies in artificial intelligence (AI)-based genome interpretation and genomic analysis technologies, as well as industry expertise.
-
AI pharmaceutical research and development is hot, and transaction cooperation has gradually become an industry trend
Time of Update: 2023-01-06
On October 11, Illumina announced a strategic research collaboration with AstraZeneca to accelerate drug target discovery by combining the strengths of both companies in artificial intelligence (AI)-based genome interpretation and genomic analysis technologies, as well as industry expertise.
-
The mergers and acquisitions of listed companies are hot, and there are 3 pharmaceutical companies in 1 day!
Time of Update: 2023-01-06
On the same day, Tailong Pharmaceutical issued an announcement on the participation of the company's wholly-owned subsidiary in the establishment of pharmaceutical industry funds and related party transactions, and the company's wholly-owned subsidiary Tailong Health intends to invest 10 million yuan to establish a new wholly-owned subsidiary Hangzhou Tailong Jintang Enterprise Management Co.
-
Latest health insurance revenue and expenditure data: Spending on new crown vaccines has decreased significantly
Time of Update: 2023-01-06
Overall, the national basic medical insurance participation rate remained stable, the total income of the medical insurance fund increased by 5.
Overall, the national basic medical insurance participation rate remained stable, the total income of the medical insurance fund increased by 5.
-
Recently, pharmaceutical companies have been keen to participate in funds and invest in biomedicine and other fields
Time of Update: 2023-01-06
【Pharmaceutical Network Industry News】On November 10, Youningwei announced that the company intends to participate in the Shanghai Leading Relay Private Equity Partnership (Limited Partnership) for 50 million yuan, which will mainly focus on digital economy, advanced manufacturing, medical and health, consumer services and other industries to carry out investment.
-
Recently, pharmaceutical companies have been keen to participate in funds and invest in biomedicine and other fields
Time of Update: 2023-01-06
【Pharmaceutical Network Industry News】On November 10, Youningwei announced that the company intends to participate in the Shanghai Leading Relay Private Equity Partnership (Limited Partnership) for 50 million yuan, which will mainly focus on digital economy, advanced manufacturing, medical and health, consumer services and other industries to carry out investment.
-
The domestic rare disease market space is large, and multinational pharmaceutical companies have increased their layout with new drugs
Time of Update: 2023-01-06
In addition, Sanofi brought a number of new drugs for rare diseases to the Expo, including the first exhibition of the world's first approved nanobody drug Cablivi, which is the first drug targeted for the treatment of acquired thrombotic thrombocytopenic purpura (aTTP).
-
In order to promote the industrialization of Chinese medicine, Chinese medicine production equipment needs to continue to innovate
Time of Update: 2023-01-06
It is believed that in the future, as more and more enterprises focus on the research and development and innovation of traditional Chinese medicine equipment, and gradually develop from a single product to a complete set of equipment, from a single equipment to provide a complete set of technical solutions, the level of traditional Chinese medicine production equipment in China will continue to improve, the industry will continue to upgrade, and promote the industrialization process of traditional Chinese medicine.
-
In order to promote the industrialization of Chinese medicine, Chinese medicine production equipment needs to continue to innovate
Time of Update: 2023-01-06
It is believed that in the future, as more and more enterprises focus on the research and development and innovation of traditional Chinese medicine equipment, and gradually develop from a single product to a complete set of equipment, from a single equipment to provide a complete set of technical solutions, the level of traditional Chinese medicine production equipment in China will continue to improve, the industry will continue to upgrade, and promote the industrialization process of traditional Chinese medicine.
-
15 billion digestion market, Top20 proprietary Chinese medicines announced (with list)
Time of Update: 2023-01-06
2022E Top 20 Proprietary Drug Brands in the Digestive System of Chinese Urban Physical Pharmacies (: 100 million yuan)Source: Competition pattern of drug terminals in China's urban physical pharmacies Note: Less than 100 million yuan is indicated by * The sales of 17 brands exceeded 100 million yuan, and Taiji Group's Chongqing Fuling Pharmaceutical's Huoxiang Zhengqi Oral Liquid, Jiangzhong Pharmaceutical's Stomach Digestion Tablets, and Zhangzhou Pian Zixi Pharmaceutical's Pian Zixi ranked in the top three.
-
15 billion digestion market, Top20 proprietary Chinese medicines announced (with list)
Time of Update: 2023-01-06
2022E Top 20 Proprietary Drug Brands in the Digestive System of Chinese Urban Physical Pharmacies (: 100 million yuan)Source: Competition pattern of drug terminals in China's urban physical pharmacies Note: Less than 100 million yuan is indicated by * The sales of 17 brands exceeded 100 million yuan, and Taiji Group's Chongqing Fuling Pharmaceutical's Huoxiang Zhengqi Oral Liquid, Jiangzhong Pharmaceutical's Stomach Digestion Tablets, and Zhangzhou Pian Zixi Pharmaceutical's Pian Zixi ranked in the top three.
-
The raw materials of the core product of Special Pharmaceutical's cough suppressant tablets are rising!
Time of Update: 2023-01-06
medicinal The market for most of the raw materials of Teyi Pharmaceutical's core product cough suppressant tablets has risen, resulting in greater cost pressure on the company and a decrease in net profit compared with last year.
-
Vigorously expanding overseas business has become the development trend of domestic pharmaceutical enterprises!
Time of Update: 2023-01-06
js?cdnversion='+~(-new Date()/36e5)];In recent years, China's biomedical industry has developed rapidly, and more and more pharmaceutical companies have begun to actively promote domestic innovative drugs overseas.
js?cdnversion='+~(-new Date()/36e5)];In recent years, China's biomedical industry has developed rapidly, and more and more pharmaceutical companies have begun to actively promote domestic innovative drugs overseas.
-
In October, 5 Class 1 new drugs were reported for production, and 7 varieties were approved for new indications
Time of Update: 2023-01-06
Overall CDE Undertaking According to the statistics of Minai. com China Declaration Progress (MED) database, CDE undertook a total of 975 drug registration applications in October 2022. Status of CDE
-
Can I participate in "Beijing Universal Health Insurance" with medical insurance from other places? Here comes the Q&A
Time of Update: 2023-01-06
A: Yes. When enrolling, what does the prompt "Please confirm whether the insured is the following groups", [new citizens, public medical care, and other medical insurance conditions that can participate in Beijing Universal Health Insurance]?
-
Xianggan, Guangdong, Hong Kong and Macao join hands to develop traditional Chinese medicine and promote the "going global" of the traditional Chinese medicine industry
Time of Update: 2023-01-06
Changsha, November 18 (Tang Xiaoqing Xu Zhen) On the 16th, the Xianggan, Guangdong-Hong Kong-Macao Traditional Chinese Medicine Industry Chain Collaborative Development Alliance (hereinafter referred
-
Internet rumor that a certain cabin hospital in Chongqing will charge? Official response: No charge
Time of Update: 2023-01-06
(End) In response to the news that a certain cabin hospital in Chongqing was going to charge on the Internet, at the press conference on epidemic prevention and control held by the Information Office of Chongqing Municipal Government on the 20th, Li Bian, deputy director of the Chongqing Municipal Health Commission, refuted the rumor that the cabin hospital did not charge.
-
Internet rumor that a certain cabin hospital in Chongqing will charge? Official response: No charge
Time of Update: 2023-01-06
(End) In response to the news that a certain cabin hospital in Chongqing was going to charge on the Internet, at the press conference on epidemic prevention and control held by the Information Office of Chongqing Municipal Government on the 20th, Li Bian, deputy director of the Chongqing Municipal Health Commission, refuted the rumor that the cabin hospital did not charge.
-
Multinational pharmaceutical companies have increased their presence in the Chinese market and deepened local cooperation
Time of Update: 2023-01-06
js?cdnversion='+~(-new Date()/36e5)];In recent years, innovative drugs are driving the rapid expansion of China's pharmaceutical market.
js?cdnversion='+~(-new Date()/36e5)];In recent years, innovative drugs are driving the rapid expansion of China's pharmaceutical market.
js?cdnversion='+~(-new Date()/36e5)];In recent years, innovative drugs are driving the rapid expansion of China's pharmaceutical market.
-
Panoramic interpretation of mRNA nanomedicines: latest progress, challenges, clinical translation and future directions
Time of Update: 2023-01-06
Their successful development has stimulated new and strong research interest in mRNA engineering and delivery technologies, providing unprecedented promise for the clinical translation of various mRNA-based therapies.
